# Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes

> **NCT06991829** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 29 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **PROCEDURE:** HLA-matched pancreatic endocrine organoids transplantation

## Key facts

- **NCT ID:** NCT06991829
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2027-04-03
- **Final completion:** 2027-10-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991829, "Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06991829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*